CNAHealth
Pathos AI joins Bristol Myers and Tempus AI
Pathos AI is partnering with Bristol Myers and Tempus AI to use artificial intelligence in drug development. The collaboration aims to improve how researchers identify promising treatments and make the process of developing new medicines more effective.
This card is an AI-assisted summary of reporting published by CNA. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.